LHNYSEServices-Medical LaboratoriesFiscal year ends December 31

LABCORP HOLDINGS INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$318.83+0.88 (+0.28%)

Close on Oct 19, 2026

Market cap: $26.14B
P/E (TTM): 26.4
Dividend yield: 0.90%

LABCORP HOLDINGS INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-31
Revenue	13,952	13,009	12,162	11,864	13,136	13,979	11,555	11,333	10,308	9,553	8,680	6,012	5,808	5,671	5,542	5,004	4,695	4,505	4,068
Cost of Revenue	9,939	9,385	8,797	8,155	8,144	9,026	8,302	8,157	7,216	6,699	5,777	3,809	3,585	3,422	3,268	2,906	2,724	2,631	2,377
Gross Profit	4,013	3,624	3,365	3,709	4,992	4,953	3,253	3,176	3,092	2,854	2,903	2,203	2,223	2,250	2,275	2,098	1,971	1,874	1,691
Selling, General & Admin	2,216	2,230	2,021	1,763	1,690	1,729	1,625	1,571	1,499	1,346	1,628	1,198	1,129	1,115	1,160	1,034	959	935	809
Operating Income	1,385	1,087	726	1,437	3,049	2,445	1,330	1,326	1,305	1,271	997	910	991	1,024	948	979	936	843	777
Interest Expense	224	208	200	180	212	207	241	244	235	219	275	110	97	95	88	70	63	-72	-57
Income from Equity Investments	-13	-1.40	-1.40	5.40	27	2.90	9.80	12	11	7.90	10	14	17	21	9.50	11	14	14	78
Other Non-Operating Income	-55	60	16	-32	16	-32	-3.20	-57	-228	-197	-271	-84	-75	-79	-82	-4.90	-3.80	-2.10	-1.40
Merger & Restructuring Charges	–	–	56	56	44	17	25	2.30	21	65	114	19	25	–	–	–	14	38	51
Asset Impairment Charges	4.30	5.30	349	262	0	462	0	0	24	0	40	0	0	–	19	–	–	–	–
Gain (Loss) on Sale of Assets	–	6.40	–	–	-12	0	-13	-185	0	9.20	-4.60	13	3.90	-5.50	-7.20	-4.10	-2.60	1.10	0.20
Legal Settlements	–	–	–	–	–	–	–	–	–	–	35	35	35	35	35	–	–	–	–
Income Tax Expense	230	212	189	234	690	662	280	384	-155	361	287	314	340	359	333	344	329	308	326
Income from Continuing Operations	878	747	380	1,004	2,198	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Income from Discontinued Operations	0	0	39	277	182	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	878	747	419	1,281	2,380	1,557	825	884	1,233	713	439	513	575	585	533	572	556	478	477
Minority Interest in Earnings	1.20	1.10	1.20	1.50	2.20	0.90	1.10	0.20	5.80	1.10	1.10	1.40	1.60	1.70	13	13	12	13	0
Net Income	877	746	418	1,279	2,377	1,556	824	884	1,227	712	438	511	574	583	520	558	543	465	477
Net Income to Common	877	746	418	1,279	2,377	1,556	824	884	1,227	712	438	511	574	583	520	558	543	465	–
EPS (Basic)(per share)	10.54	8.89	4.80	14.05	24.60	15.99	8.42	8.71	11.99	6.94	4.43	6.03	6.36	6.09	5.20	5.42	5.06	4.23	4.08
EPS (Diluted)(per share)	10.46	8.84	4.77	13.97	24.39	15.88	8.35	8.61	11.81	6.82	4.35	5.91	6.25	5.99	5.11	5.29	4.98	4.16	3.93
Shares Outstanding (Basic, Weighted)(shares)	83	84	87	91	97	97	98	101	102	103	99	85	90	96	100	103	107	110	–
Shares Outstanding (Diluted, Weighted)(shares)	84	84	88	92	98	98	99	103	104	104	101	86	92	97	102	105	109	112	–
Dividend per Share(per share)	2.88	2.88	2.88	2.16	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
EBITDA	2,066	1,730	1,303	1,974	3,626	3,070	1,907	1,878	1,838	1,770	1,455	1,156	1,221	1,253	1,180	1,182	1,131	1,023	940

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 28.9%
Operating margin: 10.4%
Net margin: 7.0%
Return on equity, FY2025: 10.5%

Financial strength

Current ratio: 1.80
Debt to equity: 0.68
Debt to assets: 31.6%
Cash to current liabilities: 6.7%

Valuation

P/E ratio: 26.4
Price to sales: 1.82
Price to book: 3.04
Dividend yield: 0.90%